1. Home
  2. LCII vs SUPN Comparison

LCII vs SUPN Comparison

Compare LCII & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCII
  • SUPN
  • Stock Information
  • Founded
  • LCII 1956
  • SUPN 2005
  • Country
  • LCII United States
  • SUPN United States
  • Employees
  • LCII N/A
  • SUPN N/A
  • Industry
  • LCII Auto Parts:O.E.M.
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LCII Consumer Discretionary
  • SUPN Health Care
  • Exchange
  • LCII Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • LCII 2.5B
  • SUPN 2.6B
  • IPO Year
  • LCII N/A
  • SUPN 2012
  • Fundamental
  • Price
  • LCII $99.16
  • SUPN $46.13
  • Analyst Decision
  • LCII Hold
  • SUPN Buy
  • Analyst Count
  • LCII 4
  • SUPN 2
  • Target Price
  • LCII $89.33
  • SUPN $43.00
  • AVG Volume (30 Days)
  • LCII 218.3K
  • SUPN 656.6K
  • Earning Date
  • LCII 11-06-2025
  • SUPN 11-03-2025
  • Dividend Yield
  • LCII 4.62%
  • SUPN N/A
  • EPS Growth
  • LCII 25.42
  • SUPN 1411.53
  • EPS
  • LCII 5.97
  • SUPN 1.14
  • Revenue
  • LCII $3,871,475,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • LCII $7.69
  • SUPN $4.84
  • Revenue Next Year
  • LCII $3.72
  • SUPN $17.69
  • P/E Ratio
  • LCII $16.65
  • SUPN $39.96
  • Revenue Growth
  • LCII 1.36
  • SUPN 5.55
  • 52 Week Low
  • LCII $72.31
  • SUPN $29.16
  • 52 Week High
  • LCII $129.38
  • SUPN $46.79
  • Technical
  • Relative Strength Index (RSI)
  • LCII 42.72
  • SUPN 64.12
  • Support Level
  • LCII $98.25
  • SUPN $43.44
  • Resistance Level
  • LCII $102.51
  • SUPN $46.72
  • Average True Range (ATR)
  • LCII 2.37
  • SUPN 1.13
  • MACD
  • LCII -0.98
  • SUPN -0.39
  • Stochastic Oscillator
  • LCII 8.86
  • SUPN 80.30

About LCII LCI Industries

LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: